1989
DOI: 10.3109/01902148909087850
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the Antiglucocorticoid RU 486 on the Maturation of Fetal Rat Lung Surfactant

Abstract: The role of endogenous glucocorticoids in the control of surfactant system maturation was investigated in the fetal rat using an antiglucocorticoid molecule synthesized by Roussel-UCLAF, RU 486. The drug was administered to the mother from day 16 of gestation on. In a preliminary step, the transplacental transfer of RU 486 and its antiglucocorticoid effects on fetal target tissues were verified by evidencing RU 486-receptor complexes in fetal liver and lung, by measuring liver glycogen content, and by evaluati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

1990
1990
1998
1998

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 33 publications
0
6
0
Order By: Relevance
“…In a previous study [3], we have shown that RU 486 treatment of pregnant rats, starting on day 16 of gestation, resulted in a slowing down of surfactant phospholipid ac cumulation in fetal lungs. However, type-II pneumocytes appeared on day 19, as in the course of normal development.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In a previous study [3], we have shown that RU 486 treatment of pregnant rats, starting on day 16 of gestation, resulted in a slowing down of surfactant phospholipid ac cumulation in fetal lungs. However, type-II pneumocytes appeared on day 19, as in the course of normal development.…”
Section: Discussionmentioning
confidence: 99%
“…The RU 486 treatment of pregnant rats from day 16 of gestation enabled us to dem onstrate unequivocally that endogenous glu cocorticosteroids (GCSs) are involved in the control of fetal lung maturation by specifi cally enhancing surfactant phospholipid bio synthesis at late stages of intrauterine devel opment [3]. However, this treatment did not prevent the appearance of type-II cells [3], responsible for surfactant biosynthesis [4], Moreover, these were first found on day 19 of gestation, i.e.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Glucocorticoids increase phospholipid production [27] and transcription of SP-B and SP-C [28] during ontogeny. Their effects on SP-A transcription during fetal develop ment are much more complex [29], In cul tured type II cell carcinoma lines, glucocorti coids increase transcription of SP-B [30].…”
Section: Discussionmentioning
confidence: 99%
“…In the context of substantial increases in circulating glucocorticoid concentrations during late gestation, these findings may be of physiologic importance to the biochemical maturation of the antenatal lung. (Pediatr Res 38: 506-512, 1995) Abbreviations GR, glucocorticoid receptor FBS, fetal bovine serum FPF, fibroblast-pneumocyte factor MEM, minimal essential medium SP-A, surfactant protein-A Glucocorticoids accelerate the onset of mature levels of surfactant synthesis by fetal mammalian lung (1-3) via the classic GR mechanism (1, 2, [4][5][6][7][8][9]. However, in many tissues, glucocorticoids decrease GR expression, thereby decreasing tissue responsiveness to glucocorticoid stimulation.…”
mentioning
confidence: 99%